Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2011

Genome-wide joint SNP and CNV analysis of aortic root diameter
in African Americans: the HyperGEN study
Nathan E. Wineinger
University of Alabama - Birmingham

Amit Patki
University of Alabama - Birmingham

Kristin J. Meyers
University of Wisconsin - Madison

Ulrich Broeckel
Medical College of Wisconsin

Charles C. Gu
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Wineinger, Nathan E.; Patki, Amit; Meyers, Kristin J.; Broeckel, Ulrich; Gu, Charles C.; Rao, DC; Devereux,
Richard B.; Arnett, Donna K.; and Tiwari, Herman K., ,"Genome-wide joint SNP and CNV analysis of aortic
root diameter in African Americans: the HyperGEN study." BMC Medical Genomics. 4,. 4. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/24

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Nathan E. Wineinger, Amit Patki, Kristin J. Meyers, Ulrich Broeckel, Charles C. Gu, DC Rao, Richard B.
Devereux, Donna K. Arnett, and Herman K. Tiwari

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/24

Wineinger et al. BMC Medical Genomics 2011, 4:4
http://www.biomedcentral.com/1755-8794/4/4
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Genome-wide joint SNP and CNV analysis of
aortic root diameter in African Americans: the
HyperGEN study
Nathan E Wineinger1*, Amit Patki1, Kristin J Meyers2, Ulrich Broeckel3, Charles C Gu4, DC Rao4, Richard B Devereux5
, Donna K Arnett6, Hemant K Tiwari1

Abstract
Background: Aortic root diameter is a clinically relevant trait due to its known relationship with the pathogenesis
of aortic regurgitation and risk for aortic dissection. African Americans are an understudied population despite a
particularly high burden of cardiovascular diseases. We report a genome-wide association study on aortic root
diameter among African Americans enrolled in the HyperGEN study. We invoked a two-stage, mixed model
procedure to jointly identify SNP allele and copy number variation effects.
Results: Results suggest novel genetic contributors along a large region between the CRCP and KCTD7 genes on
chromosome 7 (p = 4.26 × 10-7); and the SIRPA and PDYN genes on chromosome 20 (p = 3.28 × 10-8).
Conclusions: The regions we discovered are candidates for future studies on cardiovascular outcomes, particularly
in African Americans. The methods we employed can also provide an outline for genetic researchers interested in
jointly testing SNP and CNV effects and/or applying mixed model procedures on a genome-wide scale.

Background
African Americans are known to be at increased risk for
adverse cardiovascular outcomes including arterial stiffness and hypertension [1,2]. This observation makes African Americans a favorable population for genome-wide
association studies (GWAS) on traits related to cardiovascular disease. The size of the aortic root is one such
trait as it has been shown to play a major role in the
pathogenesis of aortic regurgitation and risk for aortic
dissection [3]. Enlargement of the aortic root has also
been shown to be associated with arterial blood pressure
in some studies [4-8] but not others [9] leading some
investigators to hypothesize its role in the development
of hypertension [10,11]. Despite reports of high heritability in common cardiovascular diseases, even large-scale
GWAS have failed to replicate positive associations
[12-14]. One possible explanation is that these complex
diseases may be mediated by multiple pathophysiologic
processes, such as enlargement of the aortic root, which
* Correspondence: nwineing@uab.edu
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are potentially better suited for disease-gene association
testing. Previous studies have reported linkage between
the diameter of the aortic root and candidate genes by
using an extreme-values approach [15]; and in a genome
scan [16]. A meta-analysis of GWAS results has identified
genetic variants associated with the trait on chromosomes 5, 12p, 12q, and 17 [17]. However, only individuals
of European ancestry were included.
The success of GWAS relies on the assumption that
the heritability in common diseases can be captured by
relatively few common genetic variants in the form of
single nucleotide polymorphisms (SNPs) - sometimes
referred to as the common disease, common variant
hypothesis [18,19]. However, a substantial proportion of
the heritability of many of these diseases remains left
unexplained as traditional GWAS based upon SNPs
have only accounted for a modest proportion of the
total genetic variation. Among others, copy number variation (CNV) has been cited as a potential source of this
so-called missing heritability [20].
Two recent studies have investigated the genomic
architecture of CNVs in African Americans [21,22].
These reports suggest CNVs represent a significant
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source of genetic variation in this population. We report
the results from a non-traditional GWAS on aortic root
diameter in African Americans which evaluated SNP and
copy number effects simultaneously. We gathered phenotypic and genetic data on 1,086 family members enrolled
in the HyperGEN study [23] who were genotyped on the
Affymetrix 6.0 array. We obtained SNP and CNV calls
from the Larry Bird application in Birdsuite software
[24]; and performed a two-stage, mixed model procedure
designed to identify SNP and CNV effects after controlling for potential confounders. We found two interesting
signals: one stretching between the CRCP and KCTD7
genes on chromosome 7 and the other between the
SIRPA and PDYN genes on chromosome 20.

Methods
Phenotypic data was obtained on 1,086 self-reported African American family members and individuals enrolled in
the HyperGEN study [23]. HyperGEN is one of four
Family Blood Pressure Program networks supported by
the National Heart, Lung, and Blood Institute (NHLBI) to
identify genetic contributors to hypertension. Subjects
were recruited from centers located in Birmingham, AL
and Forsyth County, NC. In the first recruitment phase of
the HyperGEN study, hypertensive sibships eligible for
recruitment consisted of probands with onset of hypertension by age 60 and one or more hypertensive siblings who
were willing to participate in the study. In the second
phase, the offspring of the hypertensive siblings were
recruited. Hypertension was defined as an average systolic
blood pressure ≥ 140 mm Hg or an average diastolic blood
pressure ≥ 90 mm Hg during at least two evaluations, or
receiving medical treatment for hypertension.
The present study cohort consisted of 421 families.
Families varied in size from single individuals to larger
families, up to 10 (Table 1). Measurements were recorded
on age, gender, height, weight, body mass index, systolic
blood pressure, diastolic blood pressure, and aortic root
diameter (Table 2). Aortic root diameter measurements
were performed during quiet respiration with twodimensional echocardiography. Aortic root was evaluated
at end-diastole at the level of the aortic annulus and the
sinuses of Valsalva in the long-axis view [25]. Measurements were made at Cornell Medical Center and verified
by an experienced investigator. Further procedures for
evaluating aortic root dimensions at the sinuses of Valsalva are described in Roman et al. [26,27]. This study
was approved by the Institutional Review Board (IRB)
and all subjects provided informed consent.
Genotyping procedures

Genetic data was obtained through the Affymetrix Genome-Wide Human SNP Array 6.0. Samples were
grouped into 34 batches in which a batch consisted of
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Table 1 Family structure of African American study
participants enrolled in HyperGEN and genotyped on the
Affymetrix 6.0 array
Family size

Families

Individuals

1

99

99

2

160

320

3

69

207

4

48

192

5
6

23
10

115
60

7

8

56

8

0

0

9

3

27

10

1

10

Total

421

1,086

all the samples that were processed on a particular day.
The Affymetrix genotyping protocol was followed. Quality control was assessed using fifty control SNPs located
on each array which were typed using a second independent platform (ABI Taqman). Genotype-based quality
control was assessed by checking markers for Mendelian
inconsistencies, potential patterns of missing data, and
allele frequency measurements (Additional file 1, S1).
SNPs and CNVs were called using Birdsuite software,
Version 1.5.5 [24]. Software parameters were kept at the
developers’ default values; and the Human Genome 18
reference build was used for probe localization. Samples
were processed by batch to eliminate batch effects. This
allows for better clustering of the data and improves
sensitivity and specificity of the algorithm compared to
combining data across batches [28]. The Larry Bird
application within Birdsuite was used to generate CNVSNP genotypes at each locus. Larry Bird combines information on copy number segment calls using the HMMTable 2 Descriptive statistics of African American study
participants enrolled in HyperGEN and genotyped on the
Affymetrix 6.0 array
n = 1,086
Age (years)

43.9 ± 13.4

Females (%)

66.6

Height (cm)

168.0 ± 90.0

Weight (kg)
BMI (kg/m2)

91.3 ± 23.9
32.5 ± 8.1

SBP (mmHg)

128.9 ± 22.2

DBP (mmHg)

73.8 ± 11.7

Center
Birmingham, AL
Forsyth County, NC
ARD (cm)

856
230
3.26 ± 0.38

Mean ± standard deviation when applicable. BMI, body mass index; SBP,
systolic blood pressure; DPB, diastolic blood pressure; ARD, aortic root
diameter.
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based Birdseye, and SNP calls using the Birdseed applications within Birdsuite. The result is a more accurate
depiction of locus-specific nucleotide frequency, particularly in non-diploid regions; and allows for the joint
modeling of allelic and copy number effects at a given
locus. Only calls with confidence values less than 0.1
were considered per the developers’ recommendation
(higher values indicate more uncertainty).
Statistical analyses

SNP and CNV joint tests of genetic association on the
logarithm of aortic root diameter (AR2D) were conducted on all autosomal SNP marker loci genotyped on
the Affymetrix 6.0 array that passed quality control
thresholds (Additional file 1, S1). The joint test was performed following an approach similar to the model proposed by Korn et al. [24]. That is, at any particular locus
containing SNP alleles labeled generically as A and B:
Y =  + 1 ( a − b ) +  2 ( a + b ) + 

(1)

where Y represents the dependent variable of interest, a is
the number of A alleles at the locus, b is the number of B
alleles at the locus, b1 corresponds to the additive SNP
allele effect, and b2 corresponds to the additive copy number effect. The joint test involves assessing the null hypothesis: b1 = b2 = 0. When either SNP allele or copy number
state is invariant, the model defaults to a single test of either
allelic or copy number effect: b1 = 0 or b2 = 0, respectively.
The model described in equation {1} can be manipulated to give investigators control over potential confounding factors by including them as covariates.
Because the HyperGEN cohort includes family data, the
model was altered into a mixed model by including random effects for each family. Furthermore, population
stratification due to genetic admixture can confound
population association studies or produce spurious
results [29-32]. To account for this problem, the first
four principal components were included in the model
as fixed effects covariates [33]. The choice of four principal components was based on examination of the associated eigenvalues (Additional file 2, Table S1). Finally,
age, age-squared, sex, and the recruitment center were
included as additional fixed effects covariates. Thus, the
full mixed model used for the analysis can be written as:
ln ( AR2D ) =  +  1 ( a − b ) +  2 ( a + b )
4

+

∑  ( PC ) + 
j

j

j =1

(

)+

5

( Age )

( Sex )
+ 8 ( Center ) +  i ( Family ) + 
+ 6 Age

2

7

(2)

where, in addition to the parameters described in {1},
jj, j = 1,...,4 are the fixed effects from the first four principal components, j5, j6, j7, j8 and are the fixed effects
for age, age-squared, sex, and recruitment center,
respectively, and gi is the family random effect of the ith
subject.
Fitting the mixed model described in equation {2} for
each SNP marker locus is currently infeasible without
approximations [34]. Because of this limitation, a twostage procedure was enacted. In the first stage, a test of
association using the GRAMMAR approach introduced
by Aulchenko et al. [35] was used to determine the
1,000 most-likely significant markers. In the second
stage, those 1,000 markers, referred to as the top 1,000,
were tested using the full mixed model described in
equation {2}. The GRAMMAR approach allows genomewide mixed model calculations to be computed on a
reasonable timescale. As part of the procedure, model
residuals for aortic root diameter measurements are
generated via mixed model after controlling for relatedness and fixed effect covariates. However, genetic effects
are not included. In terms of the present study:

i = ln ( AR2D i ) −  −

4

∑  ⋅ PC
j

i, j

j =1

−5 ⋅ age i − 6 ⋅ age i2 − 7 ⋅ sex i
− ⋅ center −  ⋅ family
8

i

i

(3)

i

= Yi*

The resulting residuals ( Yi* ) for the i th subject are
then regressed against his or her SNP allele and copy
number state at each locus in a linear model:
Y * =  + 1 ( a − b ) +  2 ( a + b ) +  .

(4)

Residuals for use in the GRAMMAR approach were
obtained from the PROC MIXED procedure in SAS ®
software, Version 9.1.2 (SAS Institute Inc., Cary, NC).
The residuals were regressed on allelic and copy number
state via lm using R version 2.10.1 [36]. Genome-wide
measurements were recorded (Figure 1). The markers
corresponding to the 1,000 most-likely significant findings using this approach were recorded; and only these
were analyzed in the full mixed model described in
equation {2}, using the lmer function in R [37]. The
most promising results are included in Table 3 and the
second stage results from all loci in the top 1,000 are
included in Additional file 3, Table S2. Genetic markers
with p-values less than 5 × 10 -7 were defined as genome-wide significant [12,17].
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Figure 1 Genome-wide results from the GRAMMAR procedure (first stage). Chromosomes are separated by color.

Results and Discussion
Genome-wide results were generated via a two-stage
procedure (see Methods). The GRAMMAR procedure
(first stage), alone, does not provide accurate parameter

estimates and significance values. The systematic
depression of the test statistic, which can be seen in
the quantile-quantile (QQ) plot (Additional file 4,
Figure S1), demonstrates that this method is inherently

Table 3 The top ten most significant markers from the first and second stages of the aortic root diameter genomewide association study
Stage 1
Chromosome

Base pair

Marker

MAF

p-value

Stage 2
SNP effect*

-5

p-value

Gene(s)
-6

3

59,877,841

rs1825630

0.444

3.70 × 10

9.46 (2.11)

7.99 × 10

FHIT

7

65,255,030

rs875971

0.324

3.99 × 10-5

10.69 (2.24)

4.09 × 10-6

CRCP

7

65,668,047

rs801193

0.337

3.97 × 10-5

11.13 (2.23)

3.65 × 10-6

LOC401365, LOC493754

7

65,700,370

rs10258739

0.318

2.11 × 10-5

10.64 (2.26)

2.50 × 10-6

7

65,733,463

AFFX 9317457

0.332

6.24 × 10-6

11.25 (2.23)

6.20 × 10-7

KCTD7, RABGEF1

7

65,733,463

rs10263935

0.324

9.06 × 10-6

11.42 (2.28)

4.26 × 10-7

KCTD7, RABGEF1

7

65,790,536

rs2659915

0.334

4.10 × 10-5

10.84 (2.22)

4.27 × 10-6

RABGEF1

8
16

117,625,451
57,316,833

rs4876662
rs12600277

0.195
0.162

2.70 × 10-5
2.84 × 10-5

13.17 (2.58)
13.99 (2.98)

2.23 × 10-6
2.72 × 10-6

GOT2

20

1,888,504

rs6045666

0.351

3.21 × 10-5

12.58 (2.26)

2.97 × 10-6

SIRPA, PDYN†

20

1,889,171

rs6045676

0.356

5.31 × 10-7

11.47 (2.28)

3.28 × 10-8

SIRPA, PDYN†

-7

The markers at rs6045676 and rs10263935 reach the threshold for genome-wide significance (p < 5 × 10 ). The last column lists known genes and proteins of
unknown function within 10 kb of the identified marker.
* The regression coefficients (10-2 scale) for the SNP effect in equation {2} and its standard error (in parentheses) are included. Meanwhile, CNV effects are
excluded due to the low observed CNV frequency at each marker (<1%).
† These genes are outside the 10 kb restriction, yet still included.
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conservative. This finding agreed with published results
[35]. Due to this limitation we implemented the GRAMMAR approach as a screening procedure. In this first
stage, the top 1,000 loci were identified. These loci
included all markers with p-values less than 2.5 × 10-3.
In general, these markers appeared to be uniform across
the genome, with the exception of a few regions. Chromosome 7, in particular, had numerous markers making
it into the top 1,000. Many of these markers were found
in a 500 kb region spanning the CRCP and KCTD7
genes. It should be noted that neither loci within genes
previously found to be associated with thoracic aortic
aneurysm (ACTA2, MYH11, TGFBR1, and TGFBR2),
nor regions previously identified as being associated
with aortic root size reached inclusion into the top
1,000 [17].
As the results from the GRAMMAR procedure, alone,
are not conclusive, we re-analyzed the top 1,000 from
the first stage using the full mixed model described in
equation {2}. We identified two regions of significance:
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the strongest signal found between the SIRPA and
PDYN genes on chromosome 20; and numerous signals
within the 500 kb region on chromosome 7 highlighted
in the first stage results. In total there were 24 marker
loci with p-values less than 1 × 10 -5 . Many of these
were located within the 500 kb region on chromosome
7 (Figure 2), but a few were found elsewhere (Table 3).
While the loci that reached or approached genomewide significance predominantly achieved that threshold based upon SNP effects, the second largest signal,
found within the KCTD7 gene on chromosome 7, was
influenced, in part, by a rare copy number variant (less
than 1%). The copy number estimate at this locus was
nearly three times its standard error. Also, a 40 kb
copy number variable region on chromosome 2 within
a gene gap between LPIN1 and TRIB2 genes showed
relatively large copy number effect estimates - about
four times its standard error. At this location, a rare
deletion was correlated with higher aortic root diameter (pCNV = 2.97 × 10-5).

Figure 2 Inspection of significance peak on chromosome 7. Linkage disequilibrium measurements (below) overlaid with results from the full
mixed model (second stage) on chromosome 7: 64,902,615 - 65,866,167 (above).
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Conclusion
African Americans have been disproportionately represented in genetic association studies on cardiovascular
traits despite a well-documented high burden of cardiovascular diseases. We implemented a non-traditional
statistical approach to test for genetic associations with
aortic root diameter in African American family members enrolled in the HyperGEN study. This method
allowed us to jointly test for SNP and CNV effect while
controlling for family structure.
We identified two novel regions of genetic association
on chromosomes 7 and 20. The significant SNPs in
each region (rs10263935 and rs6045676, respectively)
have different allele frequencies in YRI and CEU populations in HapMap [38] - providing a possible explanation
why these associations have not been observed in previous studies based on populations of European descent
[17]. The single strongest signal of genetic association
was found on chromosome 20 between the SIRPA and
PDYN genes. However, a clear relationship with either
gene to cardiovascular traits beyond the results of this
study has not been discovered. SIRPA is involved in
negative regulation with numerous growth factor signaling receptors; and PDYN has been found to be associated with nonlesional temporal lobe epilepsy [39], but
results have not been replicated [40]. Meanwhile, the
much wider region identified on chromosome 7 contains an interesting gene that has been previously found
to be related to cardiovascular outcomes: CRCP. The
product of the CRCP gene is known to interact with
CRLR to facilitate adrenomedullin (ADM) mediated signaling [41]. CRLR has been found to be significantly
decreased in the umbilical artery and uterus of women
with pregnancy-induced hypertension [42]. Also, posttranslationally modified ADM has been known to influence vasodilation [43].
The two-stage procedure, joint analysis, and ascertainment scheme offered some limitations to the present
study. First, it is possible that we missed a true association that did not pass the first stage criteria; but after
comparing the results between the loci that were
included in both steps, we are fairly comfortable as the
results were consistent across stages. Only three of the
top 1,000 did not have p-values less than 3 × 10-3 in the
second stage; and among the most significant findings,
nine were in the top ten most significant findings in
both stages. Second, the joint analyses we performed
frequently reverted back to a conventional SNP analysis
due to the majority of the genome being copy number
invariant. However, we were cautious about using a
SNP-only approach throughout the genome as it would
require us to either treat non-two-copy genotypes
as missing, or force them into a two-copy state.
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And finally, the HyperGEN sib-pair ascertainment
scheme restricted our ability to distinguish inherited
copy number variation from variants arisen through de
novo mutation as the direct transmission of CNVs from
both parents to offspring was unobservable.
We found no findings that proved copy number variation was playing a role in the pathogenesis of aortic root
diameter, but we do not believe CNVs should be ruled
out altogether. In a few cases we found large estimates
with promising significance values. Unfortunately, the
low frequency of copy number events restricted our
ability to separate their effects from more frequent
SNPs. Also, copy number variants potentially cover
numerous loci. In terms of copy number alone, we
expect perfect or near-perfect linkage disequilibrium
among those loci. Therefore, perhaps the same criteria
imposed for genome-wide significance on SNPs should
not hold for CNVs when looking at a “per locus” level.
Among those genes we identified as potentially influencing aortic root diameter, CRCP perhaps shows the
most promise. However, the large region encompassing
this gene shows strong patterns of linkage disequilibrium (Figure 2). Numerous other neighboring genes or
loci could be influencing the result. Our other primary
finding on chromosome 20 is curious as the flanking
genes and reported expression results have not previously identified this region as contributing to cardiovascular outcomes. Nonetheless, future genetic studies
on aortic root diameter and other related cardiovascular
traits should consider the regions we identified as
candidates.

Additional material
Additional file 1: S1. SNP quality control and principal component
analysis.
Additional file 2: Table S1. Eigenvalues of the top 30 principal
components.
Additional file 3: Table S2. Top 1,000 results from the second stage of
the analysis.
Additional file 4: Figure S1. Quantile-quantile plot of genome-wide
results from the first stage (GRAMMAR) procedure.
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